Miroslav Radenkovic from University of Belgrade, Serbia commenced his keynote presentation on Clinical pharmacology of sotagliflozin – Novel quality in treatment of heart failure at 2nd Edition of International Heart Congress organized by Magnus Group.
#Cardiologyconferences2024 #Cardiologyconferences #Heartcongress2024 #Cardiovascularconference #Cardiovasculardiseasesevents2024
Heart Conferences 2024
| Cardiology
Conferences | Cardiovascular
Conference 2024 | Cardiovascular
Diseases Events | Heart
Symposium 2024 | Cardiac
Summit 2024 | Cardiovascular
Summit 2024 | Cardiology
Forum 2024 | Cardiology
Summit 2024 | Cardiovascular
Symposium 2024 | Cardiology
Exhibition | Cardiovascular
Exhibition | Cardiovascular
Diseases Convention | Heart
and Vascular Colloquium | Heart
Health Forum | Cardiac
Care and Research Seminar | Advances
in Heart Disease Webinar | Cardiac
Interventions and Therapeutics Meeting
| Cardiology
Hybrid Event | Cardiovascular
Imaging and Diagnostics Symposium
| Upcoming
Cardiology Conference | Top
Cardiovascular Diseases Conferences
| Leading
Heart Congress | Innovative
cardiology conferences | Global
Heart Surgery Summit | International
Heart Diseases Expo | Cardiovascular
Colloquium | Heart
Workshop | Premier Cardiology
Conferences | Global
Cardiovascular Congress | Advances
in Heart Disease Conference | Global
Summit on Cardiac Care | Heart
Health Symposium | Cardiovascular
Medicine Gathering | World
Congress on Heart Diseases | International
Forum on Cardiac Research | Interventional
Cardiology Symposium
No comments:
Post a Comment